Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 42116713.
- Also identified by DOI 10.1002/lary.70608.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case report describes the use of targeted intracordal bevacizumab therapy for recurrent vocal fold hemorrhage refractory to conventional treatment. The intervention was associated with resolution of hemorrhagic episodes and sustained clinical improvement over follow-up. These findings suggest a potential role for antiangiogenic therapy in selected cases.